Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...

If you often wake in the middle of the night with the urgent need to urinate, urinate with growing frequency, have difficulty completely emptying your bladder, or experience pain while urinating, it ...

Concord Hospital health system is the first medical institution in New Hampshire to offer a new, FDA-approved, minimally invasive treatment option for men diagnosed with intermediate-risk prostate ...

A study by researchers at Harvard Medical School and published in the Journal of the American Medical Association showed that patients who underwent minimally invasive surgery for prostate cancer had ...

“We’re helping clinicians deliver more precise prostate cancer care by streamlining complex workflows and delivering the insights they need to support precise diagnosis and expand options for ...

Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in ...